SCHRODER INVESTMENT MANAGEMENT GROUP - SILVERBACK THERAPEUTICS INC ownership

SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 71 filers reported holding SILVERBACK THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
SCHRODER INVESTMENT MANAGEMENT GROUP ownership history of SILVERBACK THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$534,000
-50.2%
151,608
-5.9%
0.00%0.0%
Q4 2021$1,073,000
-31.1%
161,173
+3.2%
0.00%
-50.0%
Q3 2021$1,558,000
-69.2%
156,136
-4.7%
0.00%
-66.7%
Q2 2021$5,058,000
+10.9%
163,755
+56.7%
0.01%0.0%
Q1 2021$4,559,000
-57.6%
104,497
-55.0%
0.01%
-25.0%
Q4 2020$10,754,000232,0740.01%
Other shareholders
SILVERBACK THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 4,012,903$26,123,9999.73%
Nextech Invest Ltd. 1,910,029$12,434,2895.19%
K2 PRINCIPAL FUND, L.P. 2,686,490$17,489,0512.41%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 11,077,927$72,117,3051.61%
Orbimed Advisors 8,740,887$56,903,1741.12%
SECTORAL ASSET MANAGEMENT INC 793,587$5,166,2510.99%
Tejara Capital Ltd 207,555$1,351,1830.69%
Rubric Capital Management LP 3,480,712$22,659,4350.59%
Resolute Capital Asset Partners LLC 120,000$7810.57%
RA Capital Management 3,009,678$19,593,0040.44%
View complete list of SILVERBACK THERAPEUTICS INC shareholders